CLINICAL_TRIALS
trial_result
· 2017-08-17
Clinical Trial Update: Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus [Phase 1]
Summary
This entry notes the completion of a Phase 1 clinical assessment of GSK716155 for type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED